A Recombinant Vaccine of H5N1 HA1 Induces Cross-Clade Protection
Author Information
Author(s): Du Lanying, Leung Virtual Ho-Chuen, Zhang Xiujuan, Zhou Jie, Chen Min, He Wu, Zhang Hai-Ying, Chan Chris C. S., Poon Vincent Kwok-Man, Zhao Guangyu, Sun Shihui, Cai Lifeng, Zhou Yusen, Zheng Bo-Jian, Jiang Shibo
Primary Institution: Lindsley F. Kimball Research Institute, New York Blood Center, New York, New York, United States of America
Hypothesis
Can recombinant influenza vaccines provide cross-protection against divergent strains of H5N1 virus?
Conclusion
The study found that the recombinant vaccines induced strong immune responses and provided complete cross-clade protection against various H5N1 strains in mice.
Supporting Evidence
- The vaccines induced strong immune responses in vaccinated mice.
- Both vaccine candidates provided complete cross-clade protection against lethal challenges.
- Immunization with HA1-Fdc resulted in higher neutralizing antibody titers compared to HA1-Fc.
- Vaccinated mice showed significantly lower viral loads in lung tissues after challenge.
Takeaway
Scientists created a new vaccine that helps protect mice from different types of a dangerous bird flu virus.
Methodology
The study involved designing two recombinant vaccines, HA1-Fc and HA1-Fdc, and testing their immune responses and protection in a mouse model.
Limitations
The study was conducted in mice, and results may not directly translate to humans.
Participant Demographics
Female BALB/c mice aged 6–8 weeks were used in the study.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website